Viewing data from:

GATIFLOXACIN

ANDA

GATIFLOXACIN | A202653 | LUPIN LTD

1 strength0 unique patents0 unique exclusivities

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
Senju Pharmaceutical Co. Ltd. et al v. Lupin Limited et al 1:2011cv00271 2 patentsANDA 202653gatifloxacin	D. Del.	2011-03-31	Terminated 2013-08-09	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

API Supply Chain7 active DMFs7 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

KYORIN PHARMACEUTICAL CO LTDGATIFLOXACIN DRUG SUBSTANCE

DMF 155972001

DR REDDYS LABORATORIES LTDGATIFLOXACIN ANHYDROUS

DMF 170122003

MATRIX PHARMACORP PRIVATE LTDGATIFLOXACIN

DMF 170132003

APOTEX PHARMACHEM INDIA PVT LTDGATIFLOXACIN HEMIHYDRATE

DMF 206852007

LUPIN LTDGATIFLOXACIN

DMF 235522010

APITORIA PHARMA PRIVATE LTDGATIFLOXACIN HEMIHYDRATE (NON-STERILE DRUG SUBSTANCE)

DMF 264522012

STHREE CHEMICALS PRIVATE LTDGATIFLOXACIN SESQUIHYDRATE

DMF 407522024

KYORIN PHARMACEUTICAL CO LTDInactiveGATIFLOXACIN

DMF 139021998

TEVA GROUPInactiveGATIFLOXACIN

DMF 169652003

CADILA HEALTHCARE LTDInactiveGATIFLOXACIN ANHYDROUS

DMF 170022003

CADILA HEALTHCARE LTDInactiveGATIFLOXACIN SESQUIHYDRATE

DMF 170922004

HETERO DRUGS LTDInactiveGATIFLOXACIN HEMIHYDRATE

DMF 171102004

UQUIFA MEXICO SA DE CVInactiveGATIFLOXACIN HEMIHYDRATE

DMF 178222004

SIGNA SA DE CVInactiveGATIFLOXACIN HEMIHYDRATE

DMF 309992016

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Aug 29, 2013	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.5%

0 patents0 exclusivities▴

SOLUTION/DROPS;OPHTHALMIC | Approved: Aug 28, 2013

No patent or exclusivity listings for this strength.